Harmony Biosciences Holdings, Inc.

HRMY · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$51$40$46$49
Dep. & Amort.$6$6$6$6
Deferred Tax$0-$6$0-$7
Stock-Based Comp.$11$11$12$10
Change in WC$32$14-$30$16
Other Non-Cash$9$15-$1$1
Operating Cash Flow$109$79$34$76
Investing Activities
PP&E Inv.-$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$24$0-$36
Inv. Sales/Matur.$0$19$0$30
Other Inv. Act.-$5-$15$2-$1
Investing Cash Flow-$5-$20$2-$7
Financing Activities
Debt Repay.-$4-$4-$4-$4
Stock Issued$1$2$0$0
Stock Repurch.$0$0-$1$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$1$5$1
Financing Cash Flow-$3-$3-$0-$3
Forex Effect$0$0$0$0
Net Chg. in Cash$101$57$36$66
Supplemental Information
Beg. Cash$546$489$453$388
End Cash$647$546$489$453
Free Cash Flow$109$79$34$75